STE

Over the past six months, STERIS Plc's stock (STE) has experienced fluctuations, showing a 2.27% increase in the last week but a -1.19% fall over the last month and a -12.04% decrease over the last year. The stock reached its all-time high of $269.44 on January 15, 2026, and has since slipped by 22%. Recent Q1 Fiscal 2027 financial results (August 5, 2026) reported a 7% year-over-year revenue increase to $1.5 billion and diluted earnings per share (EPS) of $2.04, both surpassing estimates, driven by sustained demand for consumables and services despite some weakness in the Applied Sterilization Technologies (AST) segment. In Q2 CY2026, STERIS also met Wall Street's revenue expectations with a 7.3% year-on-year increase to $1.49 billion and beat non-GAAP profit estimates with $2.59 per share. Despite these positive earnings, the stock has underperformed the State Street Health Care Select Sector SPDR ETF (XLV) over the past three months and year. Analysts, however, maintain a "Moderate Buy" consensus rating with a mean price target suggesting a 25.4% upside.